SW, S., N, A., RH, S., KO, T., SM, H., HM, I., . . . C, J. (2025). Microbiome dysbiosis in SARS-CoV-2 infection: Implication for pathophysiology and management strategies of COVID-19. Frontiers in cellular and infection microbiology, 15, 1537456. https://doi.org/10.3389/fcimb.2025.1537456
Chicago Style (17th ed.) CitationSW, Smail, Albarzinji N, Salih RH, Taha KO, Hirmiz SM, Ismael HM, Noori MF, Azeez SS, and Janson C. "Microbiome Dysbiosis in SARS-CoV-2 Infection: Implication for Pathophysiology and Management Strategies of COVID-19." Frontiers in Cellular and Infection Microbiology 15 (2025): 1537456. https://doi.org/10.3389/fcimb.2025.1537456.
MLA (9th ed.) CitationSW, Smail, et al. "Microbiome Dysbiosis in SARS-CoV-2 Infection: Implication for Pathophysiology and Management Strategies of COVID-19." Frontiers in Cellular and Infection Microbiology, vol. 15, 2025, p. 1537456, https://doi.org/10.3389/fcimb.2025.1537456.